Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2009

01-04-2009 | Breast Oncology

Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women

Authors: Frédéric Marchal, PhD, MD, Magalie Salou, MD, Christian Marchal, MD, Anne Lesur, MD, Emmanuel Desandes, MD

Published in: Annals of Surgical Oncology | Issue 4/2009

Login to get access

Abstract

Background

Breast carcinoma in men is an uncommon disease. The aim of this study is to compare overall survival (OS) and disease-specific survival (DSS) in a group of matched men and women with breast cancer.

Methods

Each man with breast cancer recorded in the database was matched with two women. Matching was done based on age, year of diagnosis, and stage. To compare breast cancer characteristics between men and women, the chi-square test was used for qualitative data and the t-test for quantitative data. Overall survival and DSS were calculated using Kaplan-Meier methods. Cox proportional hazards models have been used to compare survival rates between men and women.

Results

The 58 male breast cancer patients were matched with 116 female patients. The mean age at diagnosis was 63.9 ± 11.9 years for men and 65.7 ± 11.5 years for women (P = .72). The median follow-up was 9.7 years for men and 10.7 years for women. The 5- and 10-year OS for men were, respectively, 58.9% and 33.9%. The 5- and 10-year OS for women were 68.2% and 52.1%. Men with breast cancer had a significant risk of dying compared with women (hazard ratio [HR] = 1.59; 95% confidence interval (95% CI), 1.04–2.42, P = .03). The 5- and 10-year DSS were 73.0% and 55.1% for men, and 72.8 and 61.2% for women, respectively. There was no difference in DSS between the two matched groups (HR = 1.26; 95% CI, 0.76–2.10, P = .37).

Conclusions

The prognosis for men with breast carcinoma is similar to that for women with similar-stage disease.
Literature
1.
Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing? Ann Surg Oncol. 2004;11:751–5.PubMedCrossRef
2.
Hill TD, Khamis HJ, Tyczynski JE, Berkel HJ. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Ann Epidemiol. 2005;15:773–80.PubMedCrossRef
3.
4.
Hill C, Doyon F. The frequency of cancer in France: all ages and under age 15, mortality in 2003 and trends since 1968. Bull Cancer. 2007;94:7–13.PubMed
5.
Brinton LA, Richesson DA, Gierach GL, Lacy JV Jr, Park Y, Hollenbeck AR, et al. Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst. 2008;100:1477–81.PubMedCrossRef
6.
Heller KS, Rosen PP, Schottenfeld D, Ashikari R, Kinne DW. Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg. 1978;188:60–5.PubMedCrossRef
7.
Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst. 1991;83:849–54.PubMedCrossRef
8.
Adami HO, Holmberg L, Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer. 1985;52:99–103.PubMed
9.
Borgen PI, Senie RT, McKinnon WM, Rosen PP. Carcinoma of the male breast: analysis of prognosis compared with matched female patients. Ann Surg Oncol. 1997;4:385–8.PubMedCrossRef
10.
Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg. 2000;66:502–11.PubMed
11.
Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the veterans affairs population: a comparative analysis. Cancer. 2007;109:1471–7.PubMedCrossRef
12.
Shuster JJ. Median follow-up in clinical trials. J Clin Oncol. 1991;9:191–2.PubMed
13.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Soc. 1958;53:457–81.
14.
Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.PubMedCrossRef
15.
Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.PubMedCrossRef
16.
Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF. A comparison outcome of male breast cancer with female breast cancer. Am J Surg. 1997;173:185–8.PubMedCrossRef
17.
Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126:775–80.PubMedCrossRef
18.
El-Tamer MB, Komenaka IK, Troxel A, Li H, Joseph KA, Ditkoff BA, et al. Men with breast cancer have better disease-specific survival than women. Arch Surg. 2004;139:1079–82.PubMedCrossRef
19.
Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat. 2004;83:77–86.PubMedCrossRef
20.
Meijer-van Gelder ME, Look MP, Bolt-de Vries J, Peters HA, Klijn JG, Foekens JA. Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat. 2001;68:249–60.PubMedCrossRef
21.
Levi F, Randimbison L, La Vecchia C. Breast cancer survival in relation to sex and age. Oncology. 1992;49:413–7.PubMedCrossRef
22.
Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538–49.PubMedCrossRef
23.
24.
Macdonald G, Paltiel C, Olivotto IA, Tyldesley S. A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann Oncol. 2005;16:1442–8.PubMedCrossRef
25.
Ragaz J, Spinelli JJ, Coldman AJ. Breast cancer survival advantage with radiotherapy. Lancet. 2000;356:1270.PubMedCrossRef
26.
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24:2268–75.PubMedCrossRef
27.
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.PubMed
28.
29.
Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist. 2005;10:471–9.PubMedCrossRef
30.
Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: a review of clinical management. Breast Cancer Res Treat. 2007;103:11–21.PubMedCrossRef
31.
Tunon de Lara C, Goudy G, Macgrogan G, Durand M, Dilhuydy JM, Avril A, et al. [Male breast cancer: a review of 52 cases collected at the Institute Bergonie (Bordeaux, France) from 1980 to 2004]. Gynecol Obstet Fertil. 2008;36:386–94.PubMedCrossRef
32.
Cutuli B, Lacroze M, Dilhuydy JM, Velten M, De Lafontan B, Marchal C, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31:1960–4.CrossRef
33.
Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94:1330–2.PubMed
34.
35.
Hemminki K, Scelo G, Boffetta P, Mellemkjaer L, Tracey E, Andersen A, et al. Second primary malignancies in patients with male breast cancer. Br J Cancer. 2005;92:1288–92.PubMedCrossRef
36.
Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, et al. Male patients with diagnoses of both breast cancer and prostate cancer. Breast J. 2003;9:208–12.PubMedCrossRef
37.
Satram-Hoang S, Ziogas A, Anton-Culver H. Risk of second primary cancer in men with breast cancer. Breast Cancer Res. 2007;9:R10.PubMedCrossRef
Metadata
Title
Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women
Authors
Frédéric Marchal, PhD, MD
Magalie Salou, MD
Christian Marchal, MD
Anne Lesur, MD
Emmanuel Desandes, MD
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0327-6

Other articles of this Issue 4/2009

Annals of Surgical Oncology 4/2009 Go to the issue

Hepatobiliary and Pancreatic Tumors

Differentiating Early and Late Recurrences After Resection of HCC in Cirrhotic Patients: Implications on Surveillance, Prevention, and Treatment Strategies

Thoracic Oncology

Pulmonary Resection for Colorectal Cancer Metastases: Duration Between Cancer Onset and Lung Metastasis as an Important Prognostic Factor

Gastrointestinal Oncology

Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer

ORIGINAL ARTICLE-THORACIC ONCOLOGY

Surgical Factors Influence the Outcome After Ivor-Lewis Esophagectomy with Intrathoracic Anastomosis for Adenocarcinoma of the Esophagogastric Junction: A Consecutive Series of 240 Patients at an Experienced Center

Thoracic Oncology

Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience

Gastrointestinal Oncology

Gastroesophageal Cancer Research, Study Design, and Continuing Dialogue